Benign Prostatic Hyperplasia (BPH) can significantly lower quality of life if left untreated. The 'Rezum' procedure is an FDA-approved technology that uses 103°C water vapor to treat the enlarged tissue. This steam causes the targeted tissue to necrotize and eventually be absorbed by the body, reducing the size of the prostate over time.
As a minimally invasive procedure, it involves no incisions and can be performed under local anesthesia in about 10-20 minutes. Because it target only specific areas, the risk of damage to surrounding healthy tissue, blood vessels, or nerves is extremely low, preserving sexual and urinary functions more effectively than traditional surgeries.
Clinical studies show a low re-treatment rate of only 4.4% over 5 years, proving its long-term reliability. Dr. Kim Tae-heon of Goldman Urology notes that Rezum is particularly suited for elderly patients or those with cardiovascular issues who cannot undergo general anesthesia.
While results appear gradually over several weeks, Rezum remains a top choice for patients seeking a quick recovery and minimal side effects.